Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular Posts Sharp Q4, FY2017 Revenue Increase

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics on Thursday posted a 427 percent jump in fourth quarter revenues, an increase driven by partnership revenues.

For the three-month period ended Dec. 31, 2017, HTG's revenues grew to $7.9 million from $1.5 million in the same period a year earlier. The company attributed the bulk of that growth to its various collaborations, which include an ongoing project with Qiagen to develop next-generation sequencing gene expression profiling assays for multiple undisclosed cancer therapies and a recently expanded companion diagnostic alliance with Merck KGaA.

The company's fourth quarter net loss fell 67 percent to $1.9 million, or $.15 per share, from $5.7 million, or $.76 per share, a year earlier. 

HTG's fourth quarter R&D spending increased to $3.6 million from $1.4 million, while its SG&A costs edged up to $4.6 million from $4.1 million.

For the full year, HTG's revenues rose 190 percent to $14.8 million from $5.1 million in 2016, while its net loss fell 27 percent to $19 million, or $1.79 per share, from $26 million, or $3.66 per share.

Its R&D spending during 2017 climbed to $10 million from $7.9 million, and SG&A expenses edged up to $17.5 million from $17.4 million.

At the end of 2017, HTG had cash and cash equivalents totaling $10 million. In January, the firm raised $40.4 million through a public offering.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.